Wenhui Zhu, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Norwalk Hospital - Yale University
Residency
National Institutes of Health Clinical Center
Fellowship
Hunan Medical University
Medical School
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
OH State Medical License Active through 2013
Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice.
Zhu, W.,Wang, L.,Zhang, L.,Palmateer, J. M.,Libal, N. L.,Hurn, P. D.,Herson, P. S.,Murphy, S. J.; Neuroscience. 2010 Jun 29.
See more >>Tumor angiogenesis as an early marker of long-term prostate cancer mortality.
Zhu, W.,Dahut, W. L.; Future Oncol. 2010 Mar 13.
See more >>Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway.
Zhu, W.,Zhu, D. S.,Madan, R. A.,Gulley, J. L.,Figg, W. D.,Dahut, W. L.; Am J Ther. 2009 Dec 19.
See more >>